Cryptocurrencies
Argenx Highlights Strategic Priorities For 2022
Regulatory News: argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced its strategic priorities for 2022 and highlighted recent achievements from Read more…